ArticleClinical immunology (Orlando, Fla.)2013

Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset.

David C Soler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.